Reckitt Benckiser Healthcare (UK) limited
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- GAVISCON ANIJS oral suspension 250 mg/5 ml+133.5 mg/5 ml
- GAVISCON CITROEN chewable tablet 250 mg+133.5 mg+80 mg
- GAVISCON CITROEN chewable tablet 500 mg+267 mg+160 mg
- GAVISCON EXTRA STERK LIQUID STICKS PEPERMUNT oral suspension 500 mg/5 ml+100 mg/5 ml
- GAVISCON EXTRA STERK oral suspension 500 mg/5 ml+100 mg/5 ml
- GAVISCON EXTRA STERK PEPERMUNT oral suspension 500 mg/5 ml+100 mg/5 ml
- GAVISCON INSTANTS MUNT powder for oral suspension 500 mg+267 mg+160 mg
- GAVISCON PEPERMUNT chewable tablet 250 mg+133.5 mg+80 mg
- GAVISCON PEPERMUNT chewable tablet 500 mg+267 mg+160 mg
- GAVISCON PEPERMUNT oral suspension 250 mg/5 ml+133.5 mg/5 ml